ARTICLE | Company News
Icagen, Pfizer deal
November 7, 2011 8:00 AM UTC
Pfizer completed its acquisition of Icagen, which will become a wholly-owned subsidiary of Pfizer. Icagen will be integrated into Pfizer's Neusentis research unit for pain, sensory disorders and regen...